News

Oxford BioSystems is pleased to announce our exclusive contract with Tecan UK to supply the IBL product range in the UK and Republic of Ireland.

Delegates at the Water Management Society (WMSoc) conference...

AID EliSpot systems are advancing all the time and everybody knows that with new technologies come updates necessary to drive them. The same can be said for the Instrumentation within your laboratory and future-proofing your testing and research capabilities is as vital now as it ever has been.

Pneumonia is a common illness affecting approximately 450 million people a year and occurring in all parts of the world. It is a major cause of death among all age groups, resulting in 4 million deaths annually – 7% of total world annual deaths.¹

Antibiotic resistance is one of the biggest threats facing us today.

Without effective antibiotics many routine treatments will become increasingly dangerous. Setting broken bones, basic operations, even chemotherapy and animal health all rely on access to antibiotics that work.

It is a well-known fact that bone is affected by chronic kidney disease (CKD). New data about the role of bone in CKD on fundamental biological pathways seems to point to the skeleton as an active inducer of pathology as a deregulated endocrine gland in kidney disease.

Human MxA protein (Myxovirus resistance protein 1), the product of the MX1 gene, is a 76-kDa protein consisting of 662 amino acid residues and belonging to the dynamic superfamily of large GTPase. MxA protein plays an important role in antiviral activity in cells against a wide variety of viruses. These include: